- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: Medicare Premium Increases Will Be Modest
What we're reading, November 11, 2016: Medicare premium increases lower than expected for high earners; HHS' Office of Inspector General will increase pharmaceutical oversight; and a study on the safety of mail-order abortion pills.
Premium increases in Medicare will be lower than initially projected. For 70% of Medicare beneficiaries, the increase will only be 4% over last year, and for the remaining beneficiaries who are high earners, the increase will be 10%, according to AP. The increase for high earners is well below the initial projected increase of as much as 22%, which had been in a June report.
The HHS Office of the Inspector General (OIG) will focus its attention on drug pricing amid concerns about the rising price of prescription medications. STAT reported that the OIG already creates such reports, but it will widen its focus to other issues, such as waste when treatments are distributed in single vials. Drug oversight is becoming a top priority for the agency.
A study is looking into the safety of abortion pills delivered by mail. According to The New York Times, researchers are trying to determine if abortions induced by medicine instead of surgery can be done safely at home with an online consultation with a doctor. Abortion opponents find the at-home, mail-order abortion pills dangerous, but advocates say the ability to receive these pills at home is a needed option for some women as access to abortion is being restricted.
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
